Silver Book Fact

A systematic review of osteoporosis therapies found good evidence that many are effective in preventing fractures, but concluded that the data are insufficient to determine if any one therapy is better than the others.

MacLean C, Newberry S, Maglione M, et al. Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis. Annals of Internal Medicine. 2008; 148(3): 186-96. http://www.ncbi.nlm.nih.gov/pubmed/18087050

Reference

Title
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
Publication
Annals of Internal Medicine
Publication Date
2008
Authors
MacLean C, Newberry S, Maglione M, et al
Volume & Issue
Volume 148, Issue 3
Pages
186-96
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • An increase in bone mineral density (BMD) testing and osteoporosis treatment was associated with a decrease in hip fracture incidence.  
  • Treatment with zoledronic acid over a 3-year period reduced risk of vertebral fracture by around 70% and risk of hip fracture by 41%, and increased bone mineral density (BMD) by…  
  • Risedronate, a bisphosphonate, has been shown to reduce vertebral fractures by around 41%, hip fractures by 30%, and non-vertebral fractures by 39%.  
  • Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to decrease vertebral fractures by up to 50% after 3 years.  
  • A study of a number of osteoporosis treatments found cost-effectiveness ratios as low as $55,000 per QALY.